Volunteer for NIAID-funded clinical studies related to malaria on ClinicalTrials.gov.
NIAID Scientists Identify Gene that Allows Malaria Parasite to Survive in Mosquitoes
Learn how NIAID is working to stop mosquito-borne diseases.
Nearly one million people die of malaria every year, mostly infants, young children, and pregnant women, and most of them in Africa. Finding effective ways to control and eventually eradicate the disease is a high priority of NIAID.
NIAID Strategic Plan for Malaria Research (PDF)
NIAID Research Agenda for Malaria (PDF, 2MB)
Media Availability: Researchers Identify Genetic Marker of Resistance to Key Malaria Drug—Dec. 18, 2013
Media Availability: NIH-Funded Scientists Describe How Mosquitoes Are Attracted to Humans—Dec. 5, 2013
Media Availability: NIH-Funded Scientists Identify Potential Target for Malaria Drugs—Nov. 27, 2013
Media Availability: NIH-Funded Researchers Identify New Insect-Repelling Compounds—Oct. 2, 2013
News from NIAID-Supported Institutions
NIAID Malaria Webinar for Reporters, April 16, 2009 (transcript)
Transcript of the NIAID Webinar for Science and Medical Reporters held April 16, 2009, titled “NIAID Malaria Research: Yesterday, Today, Tomorrow” (MS Word). Speakers included Dr. Anthony S. Fauci, NIAID director, and six other NIAID malaria experts: Drs. Martin John Rogers, Adriana Costero, Rick M. Fairhurst, Thomas E. Wellems, Susan K. Pierce, and B.F. “Lee” Hall.
Last Updated December 05, 2013